The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study

Clinical Endocrinology

Volumn 75, Issue 5, 2011, Pages 692-697

  Hosseinpanah, Farhad ^a   Barzin, Maryam ^a   Tehrani, Fahimeh R ^b   Azizi, Fereidoun ^c  

^a Obesity Research Center   (Ireland)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; IRAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; IRAN; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

EID: 80054730100     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04113.x     Document Type: Article

References (36)

1. Givens, J.R., Kurtz, B.R., Kitabchi, A.E., et al. (1987) Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans. Journal of Clinical Endocrinology and Metabolism, 64, 377-382. (Pubitemid 17001074)
2. Asuncion, M., Calvo, R.M., San Millan, J.L., et al. (2000) A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. Journal of Clinical Endocrinology and Metabolism, 85, 2434-2438. (Pubitemid 32269197)
3. Diamanti-Kandarakis, E., Kouli, C.R., Bergiele, A.T., et al. (1999) A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. Journal of Clinical Endocrinology and Metabolism, 84, 4006-4011. (Pubitemid 30644187)
4. Legro, R.S., Kunselman, A.R., &, Dunaif, A., (2001) Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. American Journal of Medicine, 111, 607-613. (Pubitemid 34088070)
5. Coviello, A.D., Legro, R.S., &, Dunaif, A., (2006) Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism, 91, 492-497. (Pubitemid 43236914)
6. Moran, L., &, Teede, H., (2009) Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Human reproduction update, 15, 477-488.
7. Glueck, C.J., Papanna, R., Wang, P., et al. (2003) Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome. Metabolism, 52, 908-915. (Pubitemid 36957780)
8. Apridonidze, T., Essah, P.A., Iuorno, M.J., et al. (2005) Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 90, 1929-1935. (Pubitemid 40586223)
9. Hahn, S., Tan, S., Sack, S., et al. (2007) Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome. Experimental and Clinical Endocrinology and Diabetes, 115, 130-135. (Pubitemid 46408122)
10. Carmina, E., Napoli, N., Longo, R.A., et al. (2006) Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. European Journal of Endocrinology, 154, 141-145. (Pubitemid 43250748)
11. Soares, E.M., Azevedo, G.D., Gadelha, R.G., et al. (2008) Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome. Fertility and Sterility, 89, 649-655. (Pubitemid 351343817)
12. Weerakiet, S., Bunnag, P., Phakdeekitcharoen, B., et al. (2007) Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the international diabetes federation criteria. Gynecological Endocrinology, 23, 153-160. (Pubitemid 46570209)
13. Haffner, S.M., D'Agostino Jr, R., Festa, A., et al. (2003) Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors? Diabetes Care, 26, 2796-2803. (Pubitemid 37205549)
14. Tsilchorozidou, T., Overton, C., &, Conway, G.S., (2004) The pathophysiology of polycystic ovary syndrome. Clinical endocrinology (Oxford), 60, 1-17. (Pubitemid 38183491)
15. Dunaif, A., Segal, K.R., Shelley, D.R., et al. (1992) Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes, 41, 1257-1266.
16. Dunaif, A., Segal, K.R., Futterweit, W., et al. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165-1174. (Pubitemid 19250404)
17. DeUgarte, C.M., Bartolucci, A.A., &, Azziz, R., (2005) Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertility and Sterility, 83, 1454-1460. (Pubitemid 40615820)
18. Goverde, A.J., van Koert, A.J., Eijkemans, M.J., et al. (2009) Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Human Reproduction, 24, 710-717.
19. Ramezani Tehrani, F., Simbar, M., Tohidi, M., et al. (2011) The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reproductive biology and endocrinology, 9, 39.
20. Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation, 120, 1640-1645.
21. Delavari, A., Forouzanfar, M.H., Alikhani, S., et al. (2009) First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care, 32, 1092-1097.
22. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41-47.
23. Chiazze Jr, L., Brayer, F.T., Macisco Jr, J.J., et al. (1968) The length and variability of the human menstrual cycle. JAMA, 203, 377-380.
24. Hatch, R., Rosenfield, R.L., Kim, M.H., et al. (1981) Hirsutism: implications, etiology, and management. American Journal of Obstetrics and Gynecology, 140, 815-830. (Pubitemid 11046650)
25. Jonard, S., Robert, Y., Cortet-Rudelli, C., et al. (2003) Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Human Reproduction, 18, 598-603. (Pubitemid 36329332)
26. Wallace, T.M., Levy, J.C., &, Matthews, D.R., (2004) Use and abuse of HOMA modeling. Diabetes Care, 27, 1487-1495. (Pubitemid 38680001)
27. Cussons, A.J., Watts, G.F., Burke, V., et al. (2008) Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Human Reproduction, 23, 2352-2358.
28. Vrbikova, J., Vondra, K., Cibula, D., et al. (2005) Metabolic syndrome in young Czech women with polycystic ovary syndrome. Human Reproduction, 20, 3328-3332. (Pubitemid 41742508)
29. Chen, M.J., Yang, W.S., Yang, J.H., et al. (2006) Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS. Human Reproduction, 21, 2266-2271.
30. Dewailly, D., Pigny, P., Soudan, B., et al. (2010) Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Mullerian hormone concentrations aggregate with the markers of hyperandrogenism. Journal of Clinical Endocrinology and Metabolism, 95, 4399-4405.
31. Kauffman, R.P., Baker, V.M., Dimarino, P., et al. (2002) Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. American Journal of Obstetrics and Gynecology, 187, 1362-1369. (Pubitemid 35397487)
32. Lobo, R.A., Granger, L.R., Paul, W.L., et al. (1983) Psychological stress and increases in urinary norepinephrine metabolites, platelet serotonin, and adrenal androgens in women with polycystic ovary syndrome. American Journal of Obstetrics and Gynecology, 145, 496-503. (Pubitemid 13138140)
33. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419. (Pubitemid 15018832)
34. Skrha, J., Haas, T., Sindelka, G., et al. (2004) Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders. Journal of Clinical Endocrinology and Metabolism, 89, 135-141. (Pubitemid 38183872)
35. Lawson, M.A., Jain, S., Sun, S., et al. (2008) Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women. Journal of Clinical Endocrinology and Metabolism, 93, 2089-2096. (Pubitemid 351831520)
36. Rosner, W., Auchus, R.J., Azziz, R., et al. (2007) Position statement: utility, limitations, and pitfalls in measuring testosterone: an endocrine society position statement. Journal of Clinical Endocrinology and Metabolism, 92, 405-413.